Critical for small bowel and intestine procedures, the scope provides adaptive bending and advanced force transmission technology for improved access and scope maneuverability in challenging anatomy. Adaptative bending of the scope also supports deeper insertion even through post-surgical adhesions of the intestinal tract. Additionally, the G7 scope handle grip design is intended to minimize stress and enable intuitive operation.
Fujifilm will demonstrate the EN-840T DBE scope at the 2025 Digestive Disease Week (DDW®) annual conference and exhibition in booth 4729 held May 3-6 in San Diego.
Ad Statistics
Times Displayed: 45002
Times Visited: 1379 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
*Fujifilm’s EN-840T DBE Scope is also available in Japan and Europe.
Suzuki S, Aniwan S, Chiu HM, Laohavichitra K, Chirapongsathorn S, et al; ATLAS Trial Group. 2023. Linked-Color Imaging detects more colorectal adenoma and serrated lesions: An international randomized controlled trial. Clin Gastroenterol Hepatol 21(6):1493-1502.e4, PMID: 36328306.
About Fujifilm
FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm’s innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The company is headquartered in Lexington, Massachusetts. For more information, please visit healthcaresolutions-us.fujifilm.com.
Back to HCB News
